ArticleFuture oncology (London, England)2024

Radiomics and PD-L1 expression predict immunotherapy benefits in patients with head and neck squamous cell carcinoma.

Yongsik Sim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.